The PD-L1 aptamer blocks the binding of PD-L1 on the tumor cell surface to PD-1 on T lymphocytes, restoring their immune function, inducing cytokine production and aggregation, and exerting an immune killing role on bladder cancer cells. This evidence concerns the gene CD274 and urinary bladder carcinoma.